Related Experiment Video
Updated: Oct 8, 2025

06:04
Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
230
Network Meta-Analysis Comparing the Short- and Long-Term Outcomes of Alternative Access for Transcatheter Aortic
Sagar Ranka1, Shubham Lahan2, Adnan K Chhatriwalla3
1Department of Cardiovascular Medicine, University of Kansas Medical Center, Kansas City, KS, United States.
Summary
Transcatheter aortic valve replacement (TAVR) via thoracic access routes like Transaortic (TAO) and Transapical (TA) is linked to higher mortality. Non-thoracic routes offer similar outcomes to standard Transfemoral (TF) access for TAVR.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
- Medical Device Technology
Background:
- Limited pooled data exists on comparative efficacy and safety of various transcatheter aortic valve replacement (TAVR) access sites.
- Previous studies primarily focused on pairwise comparisons, necessitating a comprehensive analysis of multiple access routes.
Purpose of the Study:
- To compare short- and long-term outcomes of different alternative access routes for TAVR.
- To provide a pooled estimate of the overall comparative efficacy and safety of various TAVR access strategies.
Main Methods:
- A systematic literature search of PubMed and Cochrane library databases was conducted.
- Thirty-four studies comprising 32,756 patients undergoing TAVR via Transfemoral (TF), Transaortic (TAO), Transapical (TA), Transcarotid (TC), Transaxillary/Subclavian (TSA), or Transcaval (TCV) access were included.
- A frequentist network meta-analysis using a random-effects model with TF access as the reference was performed.
Main Results:
- Transaortic (TAO) and Transapical (TA) access were associated with increased 30-day mortality compared to Transfemoral (TF) access.
- Major vascular complications were lower with Transapical (TA) and Transcarotid (TC) access versus TF.
- One-year mortality was higher with TAO and TA access compared to TF access.
Conclusions:
- Non-thoracic alternative access sites (TC, TSA, TCV) demonstrate outcomes comparable to conventional TF access for TAVR.
- Thoracic TAVR access routes (TAO, TA) are linked to elevated short- and long-term mortality risks.
